The impact of the 21-gene Recurrence Score assay on clinical decision-making in node-positive (up to 3 positive nodes) estrogen receptor-positive breast cancer patients (Q36997719)
Jump to navigation
Jump to search
scientific article published on 26 June 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | The impact of the 21-gene Recurrence Score assay on clinical decision-making in node-positive (up to 3 positive nodes) estrogen receptor-positive breast cancer patients |
scientific article published on 26 June 2013 |
Statements
1 reference
The impact of the 21-gene Recurrence Score assay on clinical decision-making in node-positive (up to 3 positive nodes) estrogen receptor-positive breast cancer patients (English)
1 reference
Salomon M Stemmer
1 reference
Shmuel H Klang
1 reference
Noa Ben-Baruch
1 reference
David B Geffen
1 reference
Mariana Steiner
1 reference
Lior Soussan-Gutman
1 reference
Shahar Merling
1 reference
Christer Svedman
1 reference
Shulamith Rizel
1 reference
Nicky Lieberman
1 reference
26 June 2013
1 reference
1 reference
83-92
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference